Tirzepatide for diabetes vs long-acting insulins demonstrated superior glycemic control and weight loss compared among adults with type 2 diabetes.

The remainder injected insulin multiple times daily. The results show that those in the semaglutide and tirzepatide groups lost significantly more weight than the controls. Almost all of those treated ...

A study suggests that weight loss medications like Ozempic may help reduce the risk of overdose and alcohol intoxication in ...

The remainder injected insulin multiple times daily. The results show that those in the semaglutide and tirzepatide groups ...

Discover why Sagimet Biosciences' Denifanstat is a top contender in treating MASH, with FDA designation and strong financials ...

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one ... blood sugar level resulting from a level of insulin resistance that isn't high enough to be considered ...

Tirzepatide, a cutting-edge medication initially approved for the treatment of type 2 diabetes, has shown remarkable potential in facilitating significant weight loss. This dual GIP and GLP-1 receptor ...

Eighty states, cities, counties, school boards and unions have joined litigation in a New Jersey district court against the three major pharmacy middlemen.

RBC Capital Markets initiated coverage on Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes ...

GLP-1 drugs such as Wegovy and Ozempic (semaglutide) and Zepbound (tirzepatide) may offer benefits that extend ... While ...

Tirzepatide: Dual Agonism and Its Potential ... Studies suggest that the peptide might influence insulin secretion, glucose metabolism, and lipid processing through its interactions with these ...